LVAD recipients were much less likely to need an opioid prescription at discharge and much more likely to be free of chronic opioids 18 months later after Cleveland Clinic launched an opioid-sparing regimen.
New protocol is striking because it shows that an opioid-sparing approach can work for patients who’ve undergone a major open-heart procedure.
A new study of over 400 patients with left ventricular assist devices adds to the mixed evidence on atrial arrhythmias in this population and provides the first systematic look at the effects of rhythm control.
Our experts share eight trends and developments that excite them most in mechanical circulatory support and beyond.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
As the use of LVADs for destination therapy grows, a new study offers the first guidance on whether aggressive treatment for atrial arrhythmias makes a difference in this setting.